Other news

u-card-img-1
News
Publication in Nature

RHOJ : contrôle de la résistance à la chimiothérapie  

Cédric Blanpain's team (WEL Research Institute - ULB) discovered that RHOJ allows cancer cells with EMT to resist chemotherapy.

Learn more
u-card-img-1
News
Publication in Nature Immunology

Capacité de prolifération inattendue des monocytes sanguins  

Thomas Marichal (WEL Research Institute - ULiège) and his team have discovered that blood monocytes, previously considered to be differentiated cells, are in fact capable of proliferating to replace tissue macrophages.

Learn more
u-card-img-1
News
Publication in Cell

CnoX: an unexpected partner for GroEL  

Jean-François Collet (WEL Research Institute - UCLouvain) and colleagues discovered that the chaperone GroEL works with CnoX, a chaperedoxin that controls the redox quality of GroEL substrates.

Learn more
u-card-img-1
News

2023 George Eisenbarth Memorial Lecture award  

Decio L. Eizirik (WEL Research Institute - ULB) is the recipient of the prestigious George Eisenbarth Memorial Lecture that will be delivered at the 15th annual Network for Pancreatic Organ Donors with Diabetes (nPOD) meeting in Florida, USA.

Learn more
u-card-img-1
News

ISSCR Momentum Award  

Cédric Blanpain (WEL Research Institute - ULB) is the winner of the Momentum Award 2023 of the International Society for Stem Cell Research (ISSCR). This is the first time that such a prestigious award has been given to a researcher based in Europe.

Learn more
u-card-img-1
News

2023 Earl P. Benditt Award  

Miikka Vikkula (WEL Research Institute - UCLouvain) is the recipient of the prestigious Earl P. Benditt Award which he will receive at the 2023 edition of the North American Vascular Biology Organization (NAVBO) meeting in Rhode Island, USA.

Learn more
u-card-img-1
News
Publication in Nucleic Acids Research

« Z » for Zalpha  

Alain Vanderplasschen (WEL Research Institute – ULiège) and his team demonstrated a key role for the Zalpha protein domain of Cyprinid herpesvirus 3 in the mechanism of viral infection in carp.  

Learn more
u-card-img-1
News
Publication in Blood

GARP in cancer: the story continues…  

Sophie Lucas’ team (WEL Research Institute - UCLouvain) showed that the strategy of blocking GARP, a novel immuno-oncology target under clinical investigation for solid cancers, also has potential in "liquid" tumours.

Learn more
u-card-img-1
News

Launch of the 2022 « WEL-T Investigator Programme” call!  

Opening on 15 December 2022 of the first "WEL-T Investigator Programme" call.

The recording of the Dec 09 information webinar in English is available here.

Learn more
u-card-img-1
News

WELBIO asbl becomes the WEL Research Institute  

The WEL Research Institute supports strategic research of excellence within its departments: WELBIO (life sciences) and WEL-T (engineering sciences, chemistry, physics) for an impact in health and sustainable transition.

Learn more
u-card-img-1
News

Rentrée des chercheuses et chercheurs WELBIO  

La « Rentrée des Chercheuses et des Chercheurs WELBIO » fut l’occasion pour WELBIO de présenter sa stratégie et ses grands axes de développement, ainsi que quelques programmes de recherche dans différents domaines, à différents stades d’évolution.

Learn more

Share this page